Cetera Advisor Networks LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$11.39 - $16.23 $496,968 - $708,147
-43,632 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$13.22 - $19.09 $22,738 - $32,834
1,720 Added 4.1%
43,632 $608,000
Q1 2021

May 17, 2021
BUY
$16.68 - $23.97 $699,092 - $1 Million
41,912 New
41,912 $776,000

Others Institutions Holding KNSA

# of Institutions
164
Shares Held
40.6M
Call Options Held
186K
Put Options Held
157K
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $636M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email